Detalhe da pesquisa
1.
The Prognostic Value of Baseline Clinical and Radiologic Imaging Features in Patients with Unresectable Hepatocellular Carcinoma Treated with Atezolizumab Plus Bevacizumab.
J Hepatocell Carcinoma
; 9: 913-927, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36065424